Sleep & Respiratory

Products

AutoSet CS2

An Adaptive Servo-Ventilator, the AutoSet CS2 has evolved from Positive Airway Pressure (PAP) ventilators. The AutoSet CS2 has been specifically designed for congestive heart failure (CHF) patients who have Cheynes-Stokes Respiration (CSR) and concomitant obstructive sleep apnoea (OSA).

Controlled trials of medically treated patients with heart failure and obstructive sleep apnoea (OSA) have shown that after one month of PAP therapy, daytime systolic blood pressure is reduced and left ventricular function is improved. It also detects Cheynes-Stokes respiration (CSR).

AutoSet CSTM 2 therapy:

• Normalises ventilation, reducing arousals from sleep and decreasing sympathetic activation

• Improves cardiac function (LVEF, 6MWD, and VO2 max)

• Enhances quality of life

This suggests that AutoSet CS2 may improve the prognosis when combined with optimised pharmacological therapy.

 

November 2018
MTWTFSS
29 30 31 1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 1 2
3 4 5 6 7 8 9